Bayer Zydus Pharma Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 50.00 Cr
- Company Age 14 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.76%
- Profit Growth 232.18%
- Ebitda 299.87%
- Net Worth 14.94%
- Total Assets 11.66%
About Bayer Zydus Pharma
Bayer Zydus Pharma Private Limited (BZPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 07 February 2011 and has a history of 14 years and one month. Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.00 Cr and a paid-up capital of Rs 50.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Bayer Zydus Pharma Private Limited India is Hemal Bhavsar as COMPANY SECRETARY. Kunal Jha and Shweta Rai serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24233MH2011PTC213118
- Company No.
213118
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Feb 2011
- Date of AGM
13 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Pharma
Bayer Zydus Pharma Private Limited
Explore comprehensive data for Bayer Zydus Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Bayer Zydus Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shweta Rai  | Managing Director | 27-Jan-2024 | Current |
| Hemal Bhavsar | Company Secretary | 15-Dec-2021 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kunal Jha | Director | 03-May-2024 | Current |
Financial Performance of Bayer Zydus Pharma.
Bayer Zydus Pharma Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 0.76% decrease. The company also saw a substantial improvement in profitability, with a 232.18% increase in profit. The company's net worth Soared by an impressive increase of 14.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bayer Zydus Pharma?
In 2023, Bayer Zydus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bayer Investments India Private LimitedKunal Jha is a mutual person
Bayer Pharmaceuticals Private LimitedKunal Jha and Shweta Rai are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bayer Zydus Pharma?
Bayer Zydus Pharma has a workforce of 713 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bayer Zydus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bayer Zydus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Bayer Zydus Pharma
Recent activity within the organization
- Annual General Meeting
Bayer Zydus Pharma Private Limited last Annual general meeting of members was held on 13 Sep 2024 as per latest MCA records.
- Director Appointment
Kunal Jha was appointed as a Director was appointed as a Director on 03 May 2024 & has been associated with this company since 10 months 17 days .
- Balance Sheet
Bayer Zydus Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
- Director Appointment
Shweta Rai was appointed as a Managing Director was appointed as a Managing Director on 27 Jan 2024 & has been associated with this company since 1 year 1 month .
- Director Appointment
Hemal Mahesh Bhavsar was appointed as a Company Secretary was appointed as a Company Secretary on 15 Dec 2021 & has been associated with this company since 3 years 3 months .
- Company Incorporation
Bayer Zydus Pharma Private Limited was registered on 07 Feb 2011 with Roc Mumbai & aged 14 years 1 month as per MCA records.
Recent News, Updates & Announcement
Biocon Biologics settles patent issue; paves way for launch of biosimilar product in Canada.Biocon Biologics has settled patent disputes with Bayer Inc and Regeneron Pharmaceuticals Inc, enabling the launch of Yesafili, an ophthalmology product for neovascular and age-related macular degeneration, in Canada by July 1, 2025..
- Sun Pharma inks pact with Bayer to sell drug for chronic kidney disease.
Sun Pharma has partnered up with Bayer to market Finerenone, a drug for chronic kidney disease, in India. Bayer grants non-exclusive rights to Sun Pharma to distribute Finerenone under the brand name Lyvelsa. Sun Pharma CEO emphasizes commitment to providing innovative medicines to Indian patients. .
- Bayer’s move to block Natco’s colorectal cancer brand dismissed by Delhi HC.
Bayer raised the objection against Natcos brand launched under the name Regonat alleging infringement of its patent rights..
Frequently asked questions
What is the Incorporation or founding date of Bayer Zydus Pharma Private Limited?
Bayer Zydus Pharma Private Limited was incorporated on 07 Feb 2011.
What is authorized share capital and paid-up capital of Bayer Zydus Pharma Private Limited?
The authorized share capital of Bayer Zydus Pharma Private Limited is ₹ 100.00 Cr and paid-up capital is ₹ 50.00 Cr.
Who are the current board members & directors of Bayer Zydus Pharma Private Limited?
Currently 3 directors are associated with Bayer Zydus Pharma Private Limited.
- Kunal Jha
- Shweta Rai
- Hemal Mahesh Bhavsar
What is the registered address of Bayer Zydus Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Bayer Zydus Pharma Private Limited is Bayer House Central Avenue Hiranandani Estate, (West) India, Thane, Maharashtra, 400607.
What is the corporate identification number (CIN) and company number of Bayer Zydus Pharma Private Limited?
The corporate identification number (CIN) of Bayer Zydus Pharma Private Limited is U24233MH2011PTC213118 and the company number is 213118 as per Ministry of Corporate Affairs (MCA).
What is the official website of Bayer Zydus Pharma Private Limited?
The Official website of Bayer Zydus Pharma Private Limited is https://www.bayerzyduspharma.com
What has been the recent revenue trend for Bayer Zydus Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Bayer Zydus Pharma Private Limited has fallen by -0.76%.
How many employees does Bayer Zydus Pharma Private Limited currently have?
As Per 2023 financial reports, 713 employees are currently employed by Bayer Zydus Pharma Private Limited.
What change has been observed in the net worth of Bayer Zydus Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Bayer Zydus Pharma Private Limited has experienced an upsurge of 14.94%.
When was the last Balance Sheet of Bayer Zydus Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Bayer Zydus Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records
People also Viewed
Ying ChenAdditional Director
Wei JiangDirector
Ulrich SteferDirector
Simon WiebuschAdditional Director
Manoj SaxenaDirector
Harish SadanaDirector
Ganesh NayakDirector
Narain DuraiswamiDirector